SCHEMBL8790045

SCHEMBL8790045

O=C(O)Cn1nnnc1-c1cccs1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.63
HDAC3 O15379 3/20 0.57
HDAC1 Q13547 3/20 0.57
HDAC2 Q92769 3/20 0.57
HDAC6 Q9UBN7 3/20 0.57
HDAC4 P56524 2/20 0.57
HDAC7 Q8WUI4 2/20 0.57
HDAC10 Q969S8 2/20 0.57
HDAC11 Q96DB2 2/20 0.57
HDAC8 Q9BY41 2/20 0.57
HDAC9 Q9UKV0 2/20 0.57
HDAC5 Q9UQL6 2/20 0.57
CYP3A4 P08684 1/20 0.57
ALDH1A1 P00352 5/20 0.54
HPGD P15428 1/20 0.54
KDM4C Q9H3R0 1/20 0.45
KDM4E B2RXH2 6/20 0.44
POLB P06746 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9568841 0.80 KMT2A (0.51) KMT2AHDAC3HDAC1HDAC2HDAC6
SCHEMBL9690737 0.80 ALDH1A1 (0.54) KMT2AHDAC3HDAC1HDAC2HDAC6
SCHEMBL11190579 0.79 KMT2A (0.50) KMT2AHDAC3HDAC1HDAC2HDAC6
SCHEMBL10401793 0.79 KMT2A (0.62) KMT2AHDAC3HDAC1HDAC2HDAC6
SCHEMBL6358690 0.78 KMT2A (1.00) KMT2AHDAC3HDAC1HDAC2HDAC6
SCHEMBL8790264 0.78 ALDH1A1 (0.55) KMT2AHDAC3HDAC1HDAC2HDAC6
SCHEMBL8792333 0.77 ALDH1A1 (0.55) KMT2AHDAC1HDAC6ALDH1A1HPGD
SCHEMBL5966693 0.76 ALDH1A1 (0.74) HDAC6ALDH1A1HPGDKDM4CKDM4E
SCHEMBL8947331 0.76 ALDH1A1 (0.84) HDAC6ALDH1A1HPGDKDM4CPOLB
SCHEMBL8790731 0.75 ALDH1A1 (0.49) KMT2AHDAC3HDAC1HDAC2HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0421365-B1 Tetrazoleacetic acid derivatives having aldose reductase inhibitory activity WAKAMOTO PHARMA CO LTD (JP) 1997-03-05 EP claimed
US-5068239-A Antidiabetic agent WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) 1991-11-26 US claimed
EP-0421365-A2 Tetrazoleacetic acid derivatives having aldose reductase inhibitory activity Wakamoto Pharmaceutical Co., Ltd. (JP) 1991-04-10 EP claimed
JP-3204875-A None JP disclosed
EP-0421365-B1 Tetrazoleacetic acid derivatives having aldose reductase inhibitory activity WAKAMOTO PHARMA CO LTD (JP) 1997-03-05 EP disclosed
US-RE35321-E ANTIDIABETIC AGENT WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) 1996-08-27 US disclosed
US-RE35321-E ANTIDIABETIC AGENT WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) 1996-08-27 US disclosed
US-5262433-A Antidiabetic agents WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) 1993-11-16 US disclosed
EP-0528277-A1 Tetrazoleacetic acid derivatives aldose reductase inhibitors Wakamoto Pharmaceutical Co., Ltd. (JP) 1993-02-24 EP disclosed
US-5068239-A Antidiabetic agent WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) 1991-11-26 US disclosed
US-5068239-A Antidiabetic agent WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) 1991-11-26 US disclosed
JP-H03204875-A TETRAZOLEACETIC ACID DERIVATIVE AND ALDOSE REDUCTASE INHIBITOR COMPRISING SAME DERIVATIVE AS ACTIVE INGREDIENT WAKAMOTO PHARMACEUT CO LTD 1991-09-06 JP disclosed
EP-0421365-A2 Tetrazoleacetic acid derivatives having aldose reductase inhibitory activity Wakamoto Pharmaceutical Co., Ltd. (JP) 1991-04-10 EP disclosed
EP-0421365-A2 Tetrazoleacetic acid derivatives having aldose reductase inhibitory activity Wakamoto Pharmaceutical Co., Ltd. (JP) 1991-04-10 EP disclosed
EP-0022245-A2 Aminothiadiazolyl derivatives, process for their preparation, pharmaceutical compositions containing them;starting compounds and process for their preparation CIBA-GEIGY AG (CH) 1981-01-14 EP disclosed
US-4207234-A 4-Unsubstituted azetidinone derivatives and process for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1980-06-10 US disclosed